Daiichi Sankyo

$27.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.05%) As of 2:13 PM UTC today

Why Robinhood?

You can buy or sell Daiichi Sankyo and other stocks, options, and ETFs commission-free!

About DSNKY

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin.

CEO
Sunao Manabe
Employees
15,348
Headquarters
Tokyo, Tokyo
Founded
2005
Market Cap
58.52B
Price-Earnings Ratio
79.64
Dividend Yield
—
Average Volume
50.32K
High Today
$27.51
Low Today
$27.30
Open Price
$27.30
Volume
35.77K
52 Week High
$38.00
52 Week Low
$22.38

You May Also Like

NOVA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure